Εμφάνιση απλής εγγραφής

dc.creatorGiamouzis, G.en
dc.creatorKalogeropoulos, A. P.en
dc.creatorButler, J.en
dc.creatorKarayannis, G.en
dc.creatorGeorgiopoulou, V. V.en
dc.creatorSkoularigis, J.en
dc.creatorTriposkiadis, F.en
dc.date.accessioned2015-11-23T10:27:54Z
dc.date.available2015-11-23T10:27:54Z
dc.date.issued2013
dc.identifier10.1007/s11897-013-0164-6
dc.identifier.issn15469530
dc.identifier.urihttp://hdl.handle.net/11615/27844
dc.description.abstractRenal dysfunction (RD) is a frequent comorbid condition and a major determinant of outcomes in patients with heart failure (HF). It is likely that the etiology of RD in patients with HF is much more complex than we first thought and represents a matrix of independent, albeit interacting, pathophysiological pathways with effects on both the kidney and the heart that share a common denominator: aging and inflammation. Renal dysfunction in HF has been attributed, among others, to biochemical, hormonal, and hemodynamic factors, coupled with pharmacological interventions. Regardless of the cause, the development of RD or worsening renal function is common in patients with HF, and is associated with increased morbidity and mortality. There is increasing evidence, however, that transient increases in creatinine in the setting of acute HF are not prognostically important, whereas persistent deterioration does portend a higher mortality in this patient population. In addition, congestion seems to play an important role in the course of renal deterioration, and the combination of congestion and worsening renal function is the most significant clinical prognosticator in HF patients. This review aims to provide an update on the epidemiology and prognostic significance of RD in HF patients, in both the acute and the chronic setting. © 2013 Springer Science+Business Media New York.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-84888053368&partnerID=40&md5=1436f13017b6284e6ddf0ad1b5dfd946
dc.subjectEpidemiologyen
dc.subjectHeart failureen
dc.subjectIncidenceen
dc.subjectPrevalenceen
dc.subjectPrognosisen
dc.subjectRenal dysfunctionen
dc.subjectcreatinineen
dc.subjectdiuretic agenten
dc.subjectdopamineen
dc.subjectlevosimendanen
dc.subjectnebivololen
dc.subjecttolvaptanen
dc.subjectacute heart failureen
dc.subjectacute kidney failureen
dc.subjectarticleen
dc.subjectcardiorenal syndromeen
dc.subjectcardiovascular mortalityen
dc.subjectchronic kidney diseaseen
dc.subjectcreatinine blood levelen
dc.subjectcreatinine clearanceen
dc.subjectdevice therapyen
dc.subjectdisease markeren
dc.subjectdiuretic therapyen
dc.subjectheart atrium fibrillationen
dc.subjectheart left ventricle hypertrophyen
dc.subjectheart transplantationen
dc.subjecthospitalizationen
dc.subjecthumanen
dc.subjecthypertensionen
dc.subjectkidney dysfunctionen
dc.subjectkidney functionen
dc.subjectkidney tubule absorptionen
dc.subjectleft ventricular assist deviceen
dc.subjectlow drug doseen
dc.subjectmorbidityen
dc.subjectmortalityen
dc.subjectquality of lifeen
dc.subjectrenal replacement therapyen
dc.subjecturea nitrogen blood levelen
dc.subjectAcute Diseaseen
dc.subjectArrhythmias, Cardiacen
dc.subjectBiological Markersen
dc.subjectCardio-Renal Syndromeen
dc.subjectChronic Diseaseen
dc.subjectComorbidityen
dc.subjectDisease Progressionen
dc.subjectHumansen
dc.subjectKidneyen
dc.subjectRenal Insufficiencyen
dc.titleEpidemiology and importance of renal dysfunction in heart failure patientsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής